|
|
Volumn 99, Issue 3, 1997, Pages 476-477
|
|
The credibility of the ACTOBAT follow-up study
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
PROTIRELIN;
DEVELOPMENTAL DISORDER;
FOLLOW UP;
MORBIDITY;
NOTE;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
RESPIRATORY DISTRESS SYNDROME;
SOCIOECONOMICS;
DATA INTERPRETATION, STATISTICAL;
DEVELOPMENTAL DISABILITIES;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GLUCOCORTICOIDS;
HUMANS;
INFANT, NEWBORN;
PREGNANCY;
PRENATAL CARE;
RESPIRATORY DISTRESS SYNDROME, NEWBORN;
THYROTROPIN-RELEASING HORMONE;
|
|
EID: 0031002905
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: 10.1542/peds.99.3.476 Document Type: Note |
|
Times cited : (6)
|
|
References (9)
|
